Davidson Trust Company’s AstraZeneca AZN Stock Holding History

Davidson Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Buy	1,211 +157	+15%	+$29.5K	0.09%	177
2026 Q1	$208K	Buy	+1,054	New	+$203K	0.09%	171

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Davidson Trust Company's AZN Position: Q2 2026 in Review

Davidson Trust Company increased its AstraZeneca (AZN) stake by 15% in Q2 2026, buying an estimated $29.5K and bringing the position to 1,211 shares worth $230K. The position accounts for 0.09% of the portfolio, ranked #177.

Davidson Trust Company first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Davidson Trust Company held 1,211 shares of AstraZeneca worth $230K as of Q2 2026.
Davidson Trust Company bought 157 AstraZeneca shares in Q2 2026, an estimated $29.5K.
AstraZeneca made up 0.09% of Davidson Trust Company's portfolio in Q2 2026, its #177 holding.
Davidson Trust Company first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Davidson Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.